Opus Genetics Ownership & Insider Activity

Opus Genetics (IRD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 12.2% of shares outstanding. Institutional investors hold 17.6%. Over the past 90 days, insiders made 6 sales worth $3.1M.

Shares Outstanding

83.196M

Shares Float

79.124M

Insider Shares Owned

10.145M

Insider % Owned

12.2%

Institutional Shares Held

14.637M

Institutional % Held

17.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$3.1M total

Net Activity

Net Selling

Net Value (90d)

-$3.1M

Opus Genetics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 23, 2026	JOSEPH SCHACHLE	CHIEF OPERATING OFFICER	SELL	4.767K	$3.56	$17K
Oct 23, 2026	BENJAMIN YERXA	PRESIDENT	SELL	33.189K	$3.54	$117K
Oct 23, 2026	Robert Gagnon	CHIEF FINANCIAL OFFICER	SELL	14.000K	$3.55	$50K
Oct 23, 2026	George Magrath	CHIEF EXECUTIVE OFFICER	SELL	9.591K	$3.58	$34K
Sep 30, 2026	Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness Inc	DIRECTOR	SELL	556.000K	$4.96	$2.8M
Sep 3, 2026	Robert Gagnon	CHIEF FINANCIAL OFFICER	SELL	28.000K	$4.54	$127K
Jul 23, 2026	BENJAMIN YERXA	PRESIDENT	SELL	7.429K	$2.97	$22K
Jul 23, 2026	JOSEPH SCHACHLE	CHIEF OPERATING OFFICER	SELL	4.644K	$2.94	$14K
Jul 23, 2026	George Magrath	CHIEF EXECUTIVE OFFICER	SELL	9.475K	$2.95	$28K
Jul 23, 2026	Robert Gagnon	CHIEF FINANCIAL OFFICER	SELL	7.783K	$2.95	$23K
May 18, 2026	Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness Inc	DIRECTOR	SELL	1.700M	$4.35	$7.4M